A recent cohort study consisting of over 700,000 Medicare patients over 65 years old evaluated the effectiveness of the herpes zoster (shingles) vaccine . Vaccination was associated with a 48% reduction in the incidence of shingles and a 59% reduction in the incidence of post-herpetic neuralgia that is often associated with shingles. One major limitation was that only 3.9% of the subjects were vaccinated. How often do older patients ask about the shingles vaccine? Based on this data, will you recommend that elderly patients receive the shingles vaccine?
For additional information, please click here.